Literature DB >> 8321911

Measurement of eicosanoids in menstrual fluid by the combined use of high pressure chromatography and radioimmunoassay.

G Hofer1, C Bieglmayer, B Kopp, H Janisch.   

Abstract

Methods are described for the quantification of various eicosanoids (cyclooxygenase products: 6-KETO, TXB2, PGE2, PGF2 alpha, DHK; lipoxygenase products: 5-, 12-, 15-HETE, LTB4, LTC4, LTD4, LTE4) in menstrual blood collected by tampons. Samples were extracted with acidified ethanol. After purification by SEP-PACK C18 columns, the compounds were separated by reversed phase HPLC using a ternary gradient system. The eicosanoid concentrations of the fractionated eluents were measured by radioimmunoassay and corrected for recovery. 12-HETE was the most prominent metabolite of arachidonic acid in menstrual blood (mean: 1174 ng/g blood). With the exception of PGF2 alpha and TXB2 (mean: 343 and 212 ng/g blood, respectively) other eicosanoids were detected in remarkable lower concentrations.

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8321911     DOI： 10.1016/0090-6980(93)90118-q

Source DB:  PubMed          Journal:  Prostaglandins        ISSN： 0090-6980


  8 in total

1.  Rapid and simultaneous quantitation of prostanoids by UPLC-MS/MS in rat brain.

Authors:  Jafar Sadik B Shaik; Tricia M Miller; Steven H Graham; Mioara D Manole; Samuel M Poloyac
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2013-11-25       Impact factor: 3.205

Review 2.  12-lipoxygenases and 12(S)-HETE: role in cancer metastasis.

Authors:  K V Honn; D G Tang; X Gao; I A Butovich; B Liu; J Timar; W Hagmann
Journal:  Cancer Metastasis Rev       Date:  1994-12       Impact factor: 9.264

3.  Prostaglandin F2alpha-F-prostanoid receptor signaling promotes neutrophil chemotaxis via chemokine (C-X-C motif) ligand 1 in endometrial adenocarcinoma.

Authors:  Alison E Wallace; Kurt J Sales; Roberto D Catalano; Richard A Anderson; Alistair R W Williams; Martin R Wilson; Jurgen Schwarze; Hongwei Wang; Adriano G Rossi; Henry N Jabbour
Journal:  Cancer Res       Date:  2009-06-23       Impact factor: 12.701

4.  Method development and validation for ultra-high pressure liquid chromatography/tandem mass spectrometry determination of multiple prostanoids in biological samples.

Authors:  Rui Yu; Guiqing Zhao; John W Christman; Lei Xiao; Richard B Van Breemen
Journal:  J AOAC Int       Date:  2013 Jan-Feb       Impact factor: 1.913

5.  A novel angiogenic role for prostaglandin F2alpha-FP receptor interaction in human endometrial adenocarcinomas.

Authors:  Kurt J Sales; Tammy List; Sheila C Boddy; Alistair R W Williams; Richard A Anderson; Zvi Naor; Henry N Jabbour
Journal:  Cancer Res       Date:  2005-09-01       Impact factor: 12.701

6.  Expression of oestrogen receptors, ERalpha, ERbeta, and ERbeta variants, in endometrial cancers and evidence that prostaglandin F may play a role in regulating expression of ERalpha.

Authors:  Frances Collins; Sheila MacPherson; Pamela Brown; Vincent Bombail; Alistair R W Williams; Richard A Anderson; Henry N Jabbour; Philippa T K Saunders
Journal:  BMC Cancer       Date:  2009-09-16       Impact factor: 4.430

7.  Prostaglandin E2 and F2alpha activate the FP receptor and up-regulate cyclooxygenase-2 expression via the cyclic AMP response element.

Authors:  Kurt J Sales; Vivien Grant; Henry N Jabbour
Journal:  Mol Cell Endocrinol       Date:  2008-02-03       Impact factor: 4.102

8.  Overexpression of AKR1C3 significantly enhances human prostate cancer cells resistance to radiation.

Authors:  Shao-Qian Sun; Xiaobin Gu; Xian-Shu Gao; Yi Li; Hongliang Yu; Wei Xiong; Hao Yu; Wen Wang; Yingbo Li; Yingqi Teng; Demin Zhou
Journal:  Oncotarget       Date:  2016-07-26
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.